Article
Rapamycin improves peripheral nerve myelination while it fails to benefit neuromuscular performance in neuropathic mice.
Neurobiology of disease - 1 Oct 2014
Nicks Jessica, Lee Sooyeon, Harris Andrew, Falk Darin J, Todd Adrian G, Arredondo Karla, Dunn William A, Notterpek Lucia
Abstract excerpt
Charcot--Marie-Tooth disease type 1A (CMT1A) is a hereditary peripheral neuropathy characterized by progressive demyelination and distal muscle weakness. Abnormal expression of peripheral myelin protein 22 (PMP22) has been linked to CMT1A and is modeled by Trembler J (TrJ) mice, which carry the same leucine to proline substitution in PMP22 as affected pedigrees. Pharmacologic modulation of autophagy by rapamycin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
